You're invited to attend our webinar on
Enhancing Your Esophageal Program by Improving Risk Stratification of Patients with Barrett’s Esophagus

Hear from GI pathologist, Robert D. Odze, MD, FRCPc, along with gastroenterologist, Anthony Infantolino, MD, AGAF, FACG, FACP of Jefferson Health. Practical application of TissueCypher in patient workflow and compelling case studies will be reviewed.



Register Here!

Don't Miss the News from Major GI Conferences in 2019


At DDW in May, Mike Hoerres, CEO, Cernostics was featured in a Roving Reporter Interview from the EndoscopyNow App.

See the full video interview by downloading the app on your mobile device.


App Store




Barrett's Esophagus & Esophageal Cancer

Three million people in the U.S. have Barrett's Esophagus, a known precursor to esophageal cancer. Until now, identifying which patients are at greatest risk for esophageal cancer has been impossible. Cernostics is looking to change that… Learn how
View All News
TissueCypher® Further Validated to Accurately Risk Stratify Barrett’s Esophagus Patients with Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences... Read More
Cernostics Announces Formation of Distinguished Medical Advisory Board Including Top Specialists in All Facets of Esophageal Disease... Read More
Blinded Independent Validation Study of Tissue Systems Pathology Test in Determining Risk of Progression to Esophageal Cancer in Patients with Barrett’s Esophagus to be Presented at DDW 2019... Read More
01/09/2017 San Francisco, CA
JP Morgan Healthcare Conference
05/06/2017 Chicago, IL
Digestive Disease Week
10/13/2017 Orlando, FL
American College of Gastroenterology
Customer Service

Mon-Fri 9am-5pm (EST)